Tirzepatide-based evidence from the SURPASS (Researching Tirzepatide in Patients with Type 2 Diabetes for Glycemic Control and Weight Management) trials (SURPASS-1 NCT03954834 and SURPASS-5 NCT04039503) demonstrated dose-dependent, significant weight loss over 40 weeks compared with placebo, along with reductions in BMI and waist circumference [62, 63]
Benefit of the product Support the function of bone, heart, and brain health
The mRNA level of LPL increased in the carnitine supplementation group in the liver in the feeding state but decreased in the muscle in the fasting state (Fig
Yu WQ, Zhang SY, Fu SQ, Fu QH, Lu WN, Zhang J, Liang ZY, Zhang Y, Liang TB
The protein in these shakes comes from pea protein, but unlike many pea protein-based powders, they dont have an earthy flavor